Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-01
2006-08-01
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S318000, C514S326000, C546S193000, C546S208000, C544S333000
Reexamination Certificate
active
07084145
ABSTRACT:
The invention provides compounds of formula (I),the pharmaceutically acceptable salts and solvates thereof, wherein A, B, R1, R2, and R7are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof as vasopressin V1Aantagonists.
REFERENCES:
patent: 6265426 (2001-07-01), Alanine et al.
patent: 574944 (1932-02-01), None
patent: 1293503 (2003-10-01), None
patent: WO 0158880 (2000-02-01), None
Kakefuda, A. et al., Bioorganic & Medicinal Chemistry, vol. 10, pp. 1905-1912, 2002, “Discovery of 4,5-Diphenyl-1,2,4-triazole Derivatives as a Novel Class of Selective Antagonists for the Human V1AReceptor.”
Kakefuda, A. et al., J. Med. Chem., vol. 45, pp. 2589-2598, 2002, “Synthesis and Pharmacological Evaluation of 5-(4-Biphenyl)-3-methyl-4-phenyl-1,2,4-triazole Derivatives as a Novel Class of Selective Antagonists for the Human Vasopressin V1AReceptor.”
Armour Robert Duncan
Baxter Andrew Douglas
Bryans Justin Stephen
Dack Kevin Neil
Johnson Patrick Stephen
Benson Gregg C.
Goddard Carl J.
McKane Joseph K.
Pfizer Inc.
Shiao Robert
LandOfFree
Triazole compounds useful in therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole compounds useful in therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole compounds useful in therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3608687